Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues
Emergent Biosolutions Inc. (EBS) had Profit Margin of -76.91% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$234.30M |
|
$-180.20M |
|
$97.10M |
|
$137.20M |
|
$359.40M |
|
$-125.10M |
|
$-41.20M |
|
$-166.30M |
|
$-166.30M |
|
$-180.20M |
|
$-180.20M |
|
$-180.20M |
|
$-180.20M |
|
$-125.10M |
|
$-99.50M |
|
51.60M |
|
51.60M |
|
$-3.49 |
|
$-3.49 |
|
| Balance Sheet Financials | |
$666.00M |
|
$178.00M |
|
$450.80M |
|
$1.12B |
|
$122.80M |
|
$581.80M |
|
$652.60M |
|
$775.40M |
|
$341.40M |
|
$79.60M |
|
$341.40M |
|
51.30M |
|
| Cash Flow Statement Financials | |
$22.30M |
|
$-54.70M |
|
$-35.80M |
|
$209.10M |
|
$140.90M |
|
$-68.20M |
|
$8.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.42 |
|
-- |
|
-- |
|
0.63 |
|
1.70 |
|
58.56% |
|
-53.39% |
|
-53.39% |
|
-- |
|
-70.98% |
|
|
Profit Margin |
-76.91% |
$18.00M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
0.32 |
|
1.23 |
|
72.98 |
|
-52.78% |
|
-226.38% |
|
-16.14% |
|
-19.52% |
|
$6.66 |
|
$0.35 |
|
$0.43 |
|